[{"address1": "3805 Old Easton Road", "city": "Doylestown", "state": "PA", "zip": "18902", "country": "United States", "phone": "617 463 9385", "website": "https://www.aprea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is APR-1051, which is in Phase 1 clinical trial for treatment of advanced solid tumors with biomarkers that may predict sensitivity to WEE1 inhibition. Its pipeline includes the ATRN-119, an ATR inhibitor that is in a Phase 1/2a clinical trials for treating advanced solid tumors having at least one mutation in a defined panel of DDR-related genes. It also includes an early-stage program, which is in lead optimization stage for an undisclosed DNA-damage response (\u0093DDR\u0094) target. The company is headquartered in Doylestown, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Oren  Gilad Ph.D.", "age": 56, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 575490, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lars B. Abrahmsen Ph.D.", "age": 67, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Wiley", "age": 56, "title": "Senior Vice President of Corporate Development & Strategy", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michel  Afargan Ph.D.", "title": "Head of Pharmacology Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ze'ev  Weiss B.Sc., C.P.A.", "age": 62, "title": "Chief Business Advisor", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  Epstein", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.62, "open": 1.62, "dayLow": 1.58, "dayHigh": 1.66, "regularMarketPreviousClose": 1.62, "regularMarketOpen": 1.62, "regularMarketDayLow": 1.58, "regularMarketDayHigh": 1.66, "payoutRatio": 0.0, "beta": 1.621, "forwardPE": -1.5588236, "volume": 11242, "regularMarketVolume": 11242, "averageVolume": 26498, "averageVolume10days": 11360, "averageDailyVolume10Day": 11360, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 8910138, "fiftyTwoWeekLow": 1.412, "fiftyTwoWeekHigh": 5.9, "priceToSalesTrailing12Months": 5.9298887, "fiftyDayAverage": 2.19906, "twoHundredDayAverage": 3.168365, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -12806617, "profitMargins": 0.0, "floatShares": 4024833, "sharesOutstanding": 5491950, "sharesShort": 60369, "sharesShortPriorMonth": 55649, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.011, "heldPercentInsiders": 0.11773, "heldPercentInstitutions": 0.41339, "shortRatio": 2.16, "shortPercentOfFloat": 0.0148, "impliedSharesOutstanding": 5603860, "bookValue": 3.523, "priceToBook": 0.4513199, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -12958711, "trailingEps": -2.35, "forwardEps": -1.02, "lastSplitFactor": "1:20", "lastSplitDate": 1676246400, "enterpriseToRevenue": -8.523, "enterpriseToEbitda": 0.896, "52WeekChange": -0.68725413, "SandP52WeekChange": 0.07995045, "quoteType": "EQUITY", "currentPrice": 1.59, "targetHighPrice": 20.0, "targetLowPrice": 10.0, "targetMeanPrice": 13.66667, "targetMedianPrice": 11.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 22849884, "totalCashPerShare": 4.161, "ebitda": -14297337, "totalDebt": 0, "quickRatio": 6.799, "currentRatio": 7.015, "totalRevenue": 1502581, "revenuePerShare": 0.273, "returnOnAssets": -0.38387, "returnOnEquity": -0.66655, "grossProfits": -7860956, "freeCashflow": -9290117, "operatingCashflow": -13556718, "revenueGrowth": 13.623, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -15.674339, "financialCurrency": "USD", "symbol": "APRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1570109400000, "regularMarketChange": -0.029999971, "regularMarketDayRange": "1.58 - 1.66", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 26498, "fiftyTwoWeekLowChange": 0.17800009, "fiftyTwoWeekLowChangePercent": 0.1260624, "fiftyTwoWeekRange": "1.412 - 5.9", "fiftyTwoWeekHighChange": -4.31, "fiftyTwoWeekHighChangePercent": -0.73050845, "fiftyTwoWeekChangePercent": -68.72541, "earningsTimestamp": 1742905800, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.35, "epsForward": -1.02, "epsCurrentYear": -0.72, "priceEpsCurrentYear": -2.2083333, "fiftyDayAverageChange": -0.60905993, "fiftyDayAverageChangePercent": -0.27696377, "twoHundredDayAverageChange": -1.578365, "twoHundredDayAverageChangePercent": -0.49816388, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1745611200, "exchange": "NCM", "messageBoardId": "finmb_329831339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Aprea Therapeutics, Inc.", "longName": "Aprea Therapeutics, Inc.", "regularMarketChangePercent": -1.85185, "regularMarketPrice": 1.59, "marketState": "CLOSED", "displayName": "Aprea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-26"}]